Your Location:
Home >
Browse articles >
Effect of Modified Liu Junzitang and Erchentang on Hcy, NO, hs-CRP in Patients with Coronary Heart Disease
Effect of Modified Liu Junzitang and Erchentang on Hcy, NO, hs-CRP in Patients with Coronary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 18, Pages: 24-29(2020)
DOI: 10.13422/j.cnki.syfjx.20201723
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 9 )
References
Publication Info
Metrics
89
Views
65
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Erchentang Alleivates Depression in Obese Mice by Regulating PPAR Signaling Pathway
Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Xuefu Zhuyutang Treats Coronary Heart Disease with Blood Stasis Syndrome in Rats via SIRT3 Signaling Pathway-mediated Regulation of Endothelial Function
Erchentang Ameliorates SiO2-induced Lung Injury by Regulating Oxidative Stress and Metabolic Disorders via Nrf2/HO-1 Signaling Pathway
Mechanism of Erchentang Improving Obesity in Mice by Inducing Browning of White Adipose Tissue Based on AMPK/PGC-1α Signaling Pathway
Related Author
YU Qiao
HU Shiwei
ZHANG Jinrong
XU Jun
ZHAO Min
ZHAO Yanzhen
BAI Siyang
JIAN Weixiong
Related Institution
Central Theater Command General Hospital of the People's Liberation Army
School of Basic Medical Sciences, Hubei University of Chinese Medicine
Hubei Shizhen Laboratory
Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics,College of Chinese Medicine,Hunan University of Chinese Medicine
Hunan University of Chinese Medicine


